Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Services

Figma a dumb deal? Imagine what a $20bn CVC fund would have…

Instead of buying Figma for $20bn Adobe might have been better served by expanding its CVC programme. A deal to take out one competitor is standard business practice but doesn’t fix Adobe’s burning platform.


Sep 16, 2022

The Standout Six: Deals you need to note this week

Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.

Sep 16, 2022

A resurgence in telecoms funds?

Telecoms investment funds had a boom in 2014-16 which has not been repeated since. But 2021 saw signs of an uptick with telcos in emerging markets creating investment funds.

Sep 16, 2022

Telecoms incumbents part of $50bn worth of exits in 2021

Telecoms companies had 91 exits for their portfolio companies last year, with an estimated total value of $50bn.

Sep 16, 2022

Investments in telecoms startups halved in 2021

Corporate investors shied away from big funding rounds for telecoms startups, with the value of deals down to $2.42bn in 2021 from $5.14bn the year before.

Sep 16, 2022

What is strategic investing for a telecoms company in 2022?

As telecoms networks continue to expand their services, what even counts as a strategic investment these days? A selection of industry figures tell Global Venturing it can include Web3, ESG and 5G-related technologies.

Sep 16, 2022

Daily Deal Round Up: September 15, 2022

Next47 has participated in a $205m series D round for Verkada while UPMC Enterprises has co-led SparingVision’s $75m series B.

Sep 15, 2022

How CVCs can survive a downturn — 6 tips from JetBlue and…

Invest in a business development function — early. Be creative with funding and careful with how your strategic value is measured.

Sep 15, 2022

Daily Deal Round Up: September 14, 2022

Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Sep 14, 2022

10 spinouts to watch: September 2022

Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.

Sep 14, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here